Abstract

Knowledge gaps in fibrotic interstitial lung disease in pan-Asian populations: data not missing at random?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
... Vicky Tsipouri
The Lancet Respiratory Medicine | VOL. 6
, et. al. ... Vicky Tsipouri
28 Aug 2018
Transbronchial Cryobiopsy Is Superior to Forceps Biopsy for Diagnosing both Fibrotic and Non-Fibrotic Interstitial Lung Diseases
Tzlil Hershko ... Nevo Barel
Respiration | VOL. 102
Tzlil Hershko, et. al.Tzlil Hershko ... Nevo Barel
25 Aug 2023
Quantitative computed tomography and machine learning: recent data in fibrotic interstitial lung disease and potential role in pulmonary sarcoidosis.
Athol U Wells ... Simon L.F Walsh
Current opinion in pulmonary medicine | VOL. 28
Athol U Wells, et. al.Athol U Wells ... Simon L.F Walsh
22 Jul 2022
Predictive factors for dose reduction and discontinuation of nintedanib in fibrotic interstitial lung diseases: Real life data
Márcio Cunha Rodrigues ... Ana Rita Pedroso
Respiratory Medicine | VOL. 225
Márcio Cunha Rodrigues, et. al.Márcio Cunha Rodrigues ... Ana Rita Pedroso
19 Mar 2024
View more papers

More From: The Lancet Respiratory Medicine

Paper Title
Journal
Date
Author
Continuous positive airway pressure is here to stay
Atul Malhotra ... Jeremy H Pettus
The Lancet Respiratory Medicine | VOL. -
Atul Malhotra, et. al.Atul Malhotra ... Jeremy H Pettus
01 May 2024
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
Robert P Frantz ...
The Lancet Respiratory Medicine | VOL. -
Robert P Frantz, et. al.Robert P Frantz ...
01 May 2024
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial
Eric Lim ... Chris A Rogers
The Lancet Respiratory Medicine | VOL. 12
Eric Lim, et. al.Eric Lim ... Chris A Rogers
01 May 2024
MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma
Federica Grosso ... Alessandra Curioni-Fontecedro
The Lancet Respiratory Medicine | VOL. 12
Federica Grosso, et. al.Federica Grosso ... Alessandra Curioni-Fontecedro
01 May 2024
View more papers